Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Buy
1,206
+14
+1% +$4.79K 0.24% 102
2026
Q1
$419K Sell
1,192
-31
-3% -$11.1K 0.27% 100
2025
Q4
$400K Sell
1,223
-48
-4% -$15.2K 0.26% 98
2025
Q3
$359K Buy
1,271
+12
+1% +$3.48K 0.2% 119
2025
Q2
$352K Buy
1,259
+39
+3% +$11K 0.23% 110
2025
Q1
$380K Sell
1,220
-30
-2% -$8.86K 0.31% 92
2024
Q4
$326K Buy
+1,250
New +$371K 0.27% 101

Other funds holding AMGN

Leigh Baldwin & Co's AMGN Position: Q2 2026 in Review

Leigh Baldwin & Co increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $4.79K and bringing the position to 1,206 shares worth $437K. The position accounts for 0.24% of the portfolio, ranked #102.

Leigh Baldwin & Co first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Leigh Baldwin & Co held 1,206 shares of Amgen worth $437K as of Q2 2026.
  • Leigh Baldwin & Co bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
  • Amgen made up 0.24% of Leigh Baldwin & Co's portfolio in Q2 2026, its #102 holding.
  • Leigh Baldwin & Co first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.